|
1
|
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
|
Ann Rheum Dis
|
2012
|
3.47
|
|
2
|
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
|
Arthritis Rheum
|
2012
|
2.25
|
|
3
|
Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.
|
Arthritis Rheum
|
2010
|
1.67
|
|
4
|
Patient-reported outcomes in polymyalgia rheumatica.
|
J Rheumatol
|
2012
|
1.20
|
|
5
|
Psoriatic arthritis: a systematic review.
|
Int J Rheum Dis
|
2010
|
1.07
|
|
6
|
Diagnosis and treatment of giant cell arteritis.
|
Drugs Aging
|
2008
|
1.03
|
|
7
|
Are polymyalgia rheumatica and giant cell arteritis the same disease?
|
Semin Arthritis Rheum
|
2004
|
0.98
|
|
8
|
Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study.
|
Arthritis Rheum
|
2006
|
0.95
|
|
9
|
Isolated knee monoarthritis heralding resectable non-small-cell lung cancer. A paraneoplastic syndrome not previously described.
|
Ann Rheum Dis
|
2007
|
0.89
|
|
10
|
Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study.
|
Biologics
|
2013
|
0.86
|
|
11
|
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study.
|
Biologics
|
2012
|
0.82
|
|
12
|
Infliximab in psoriatic arthritis.
|
J Rheumatol Suppl
|
2012
|
0.80
|
|
13
|
Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study.
|
Int J Rheum Dis
|
2012
|
0.79
|
|
14
|
Fat suppression magnetic resonance imaging in shoulders of patients with polymyalgia rheumatica.
|
J Rheumatol
|
2004
|
0.79
|
|
15
|
Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes.
|
Int J Rheum Dis
|
2011
|
0.77
|
|
16
|
Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients.
|
Biologics
|
2011
|
0.77
|
|
17
|
Criteria, frequency, and duration of clinical remission in psoriatic arthritis patients with peripheral involvement requiring second-line drugs.
|
J Rheumatol Suppl
|
2009
|
0.75
|